HepTcell Immunotherapy in Patients With Inactive Chronic Hepatitis B (CHB)
Trial details
- Registry ID
- NCT04684914
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| HepTcell Immunotherapy in Patients With Inactive Chronic Hepatitis B (CHB)NCT04684914 | ALT | Phase 2 | Terminated | 2024-03-27Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |